T1	Participants 1141 1189	14 participants with ASD and 14 matched controls
T2	Participants 1414 1428	16 human faces
T3	Participants 1522 1732	The baseline fixation patterns for the ASD and control groups did not significantly differ; however, administration of propranolol was associated with a significant reduction in mouth fixation for the ASD group
